ClinicalTrials.Veeva

Menu

Clinical and Hemodynamic Evaluation After Venous Recanalization of Post-thrombotic Iliofemoral Syndromes (CHEVROPIS)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Venous Recanalisation

Treatments

Other: Basic demographic information

Study type

Observational

Funder types

Other

Identifiers

NCT05954663
69HCL22_1131

Details and patient eligibility

About

Post-thrombotic syndrome (PTS) is the most common chronic complication of deep vein thrombosis (DVT). The endovascular recanalization and stenting technique has become the gold standard treatment for medically resistant and disabling PTS.

Stent thrombosis is a significant complication of this procedure; the risk factors for thrombosis are poorly understood.

Monitoring the patency of the stent is a key component in maintaining clinical success.

Doppler ultrasound is the first-line diagnostic tool for monitoring patients with venous stents, and has the potential to allow accurate assessment of venous stent obstruction.

Absence of validated morphological and hemodynamic echodoppler criteria for the follow-up of these stents.

• Main objective: Clinical and hemodynamic results of venous recanalisations by stenting in the chronic phase

• Secondary objective (s):

  • External validation of hemodynamic criteria proposed in the literature to detect venous stent obstruction
  • Risk factors for venous stent restenosis

Enrollment

24 patients

Sex

All

Ages

18 to 67 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Disabling post-thrombotic syndrome (venous claudication) after at least 6 months of proximal deep vein thrombosis.

Exclusion criteria

  • Inability to consent
  • Age <18 years old
  • Life expectancy <3 months
  • Incomplete medical records
  • Lost in follow up

Trial design

24 participants in 1 patient group

Patients who underwent venous recanalization by angioplasty-stenting
Description:
Patients who underwent venous recanalization by angioplasty-stenting for post-thrombotic iliofemoral syndromes from June 2014 to June 2021.
Treatment:
Other: Basic demographic information

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems